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Introduction
Deep venous thrombosis (DVT) is a common com-
plication in patients who are hospitalized or bed ridden.
Lower extremity orthopaedic surgery is recognized in
Western countries as being associated with an exceptionally
high risk of developing DVT and pulmonary embolism.
Accordingly, prophylactic treatment of DVT has been estab-
lished as the standard medical practice for lower extremity
large joint replacement surgery in the Western countries. In
contrast, DVT has received little medical attention in Asian
countries because of a presumed low prevalence, conse-
quently the prophylaxis modalities are not conducted rou-
tinely.1,2
Among all the drugs, Low Molecular Weight
Heparins (LMWH) have received the most attention, but
LMWH are not without side effects and are not 100% effec-
tive.2,3
The efficacy and safety of these drugs have not been
studied in our population. The study was done to evaluate
the practice of giving LMWH in terms of efficacy and safe-
ty in patients undergoing total knee replacement surgery.
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Abstract
Objective: To evaluate the efficacy and safety of the low molecular weight heparin as prophylaxis against throm-
boembolism following total knee replacement surgery. 
Methods: Post-operative bilateral lower extremity colour duplex scan was performed on 55 patients subjected
to total knew arthroplasty. The scan was performed 7 days after surgery for detection of DVT. All patients were
given Enoxaparin 40mg subcutaneous daily for 2 weeks as prophylaxis against DVT. 
Results: Two patients were diagnosed as DVT by color duplex scanning and both were distal but only one was
asymptomatic. Another patient developed pulmonary embolism and died subsequently. The major and minor
wound problems were seen in two and six patients respectively; nearly all complications were seen in obese
patients.
Conclusion: DVT is not a nonexistent entity in our population. Low molecular weight heparins are safe drugs
but apparently the bleeding complications are more as compared to Western literature. Larger case control stud-
ies are required to determine the true efficacy and safety of LMWH (JPMA 56:72;2006).
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Patients and Methods
This observational cohort study was conducted at the
Orthopaedic Division, Department of Surgery, of Aga Khan
University Hospital, Karachi. All patients undergoing total
knee arthroplasty constituted the target population. Patients
having coagulation disorders or who were taking procoagu-
lants or anticoagulants including anti-platelet drugs and
Aspirin or who developed DVT in the past were excluded.
Informed written consent was taken from every patient
included in the study.
In all patients, prothrombin time (PT) and activated
prothrombin time (APT) were done pre-operatively and
those having abnormal values were excluded from study.
All patients received 40mg Enoxaparin subcutaneously on
anterior abdominal wall, night before surgery. Enoxaparin
(40mg) was then repeated on first postoperative day and
continued for a total duration of two weeks after surgery. 
All surgeries were done under tourniquet control. All
patients received two doses of prophylactic antibiotics.
After surgery, all were managed according to the existing
clinical pathways for total knee replacements at our institu-
tion, in the form of mobilization and range of motion of
knee joints starting at 1st postoperative day. No other form
of DVT prophylaxis was used like compression stockings.
The patients were monitored daily for symptoms and
signs of DVT as well as major and minor haemorrhagic
complications. All were subjected to mandatory bilateral
Colour Duplex Scanning of both lower limbs by the same
radiologist at postoperative day 7 or earlier if clinically indi-
cated. All patients were assessed clinically at removal of
stitches for the presence of DVT. Patients were also seen at
3 weeks after surgery and again assessed clinically for pres-
ence or absence of sign and symptoms of DVT.
Demographic and operative characteristics of
patients were recorded. Type of surgery, diagnosis, side of
surgery, age, body mass index, use of bone cement and
operating time all are considered potential risk factors. The
data thus obtained was analyzed using SPSS software ver-
sion 10.
Results
Initially 63 patients were included in the study.
Postoperatively, 8 were excluded because of improper fol-
low-up after discharge, inability to undergo bilateral colour
Doppler examination of both extremities. These patients
were followed later for the presence of symptomatic DVT.
None had any evidence of DVT. Finally 55 patients quali-
fied for the study.
The mean age of the patients was 66 years with a
range of 35 to 77, with females being older, F:M::68:60
years. The male to female ratio was 1:2.5. 
The mean hospital stay of the patients was 9.5 days
with a range of 7 to 14. The mean body weight was 74kg
(162.8lb), with a range of 55kg to 110kg. The body mass
index was 28.9kg/m2 (normal range 20.5-25 in females and
21-25.5 in the male). The upper limit for the morbid obesi-
ty is considered 35kg/m2.4
Sixty-nine percent of surgeries were done in general
anaesthesia using Sodium Pentothal and Isoflurane with the
remaining being given spinal or epidural anesthesia. 
Postoperatively majority of the cases received intra-
venous opioid analgesics for pain management. Some cases
received nonopioid analgesics due to hypersensitivity or
associated medical conditions such as respiratory insuffi-
ciency.
Sixty-two percent patients had simultaneous surgery.
Both knee joints were operated together by two operating
teams, while in 25% of the cases the surgery was performed
on one knee joint only. In 13% cases, patients underwent
surgery in two stages in the same hospital admission with
the second replacement done about 7 to 10 days after the
first surgery.
The postoperative wound related complications were
divided into two groups, major and minor wound problems.
The major required surgical intervention in the form of
wound exploration or drainage of haematoma. The minor
wound problems were managed successfully by conserva-
tive methods. In the presented study, there were 6 minor and
2 major wound problems. The later included 2 cases of
wound dehiscence who were subjected to reclosure of the
wound. The minor wound problems comprised of swelling
of the knee joint, erythema around the wound margins and
wound discharge. All of them were managed successfully
with conservative treatment. When the minor wound related
problems were analyzed, five of six patients were having
body mass index above 30kg/m2 and there was only one
patient with body mass index was less than 30kg/m2 (p-
value <0.001). In patients where major wound problems
were identified, all patients were having a body mass index
of more than 30kg/m2 (p-value <0.001).
In our study, Doppler ultrasonography was done in
all patients and it was found that 2 patients had asympto-
matic DVT and two independent radiologists confirmed the
diagnosis. DVT was present in both cases on the operated
side and in both distal veins were involved. One patient had
been subjected to bilateral knee arthroplasty and one under-
went unilateral knee arthroplasty.
One patient subjected to unilateral arthroplasty,
developed pulmonary embolism as a consequence of DVT
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and ultimately expired. The postoperative recovery was
uneventful and patient was discharged on 9th postoperative
day. He presented on 16th postoperative day with sudden
onset of dyspnoea and chest discomfort.
Electrocardiography, chest x-rays and cardiac enzymes
excluded myocardial infarction. The diagnosis of pul-
monary embolism was made by exclusion. The patient
expired within 24 hours of presentation. 
The mean requirement of blood in the form of
packed cells was 1.4 pints with a range 0 to 5. Requirement
was more in the cases of the bilateral knee replacement as
compared to unilateral knee replacement surgery. There was
no major difference observed between the simultaneous
bilateral and staged bilateral procedure i.e. 1.7 and 1.5
respectively. 
Among other complications, one patient developed
myocardial infarction in the postoperative period while one
patient developed heart failure; both of them were managed
in the coronary care unit and survived.
The local tolerance at the site of the injection was
good in majority of the patients, however, few patients com-
plained of burning sensations on anterior abdominal wall
for few weeks postoperatively. These abnormal sensations
also resolved spontaneously.
Discussion
Venous thromboembolism is a potentially serious
complication of arthroplastic surgery of lower extremity.
Without prophylaxis, approximately 40% to 50% of total
hip replacements and 50% to 70% of knee arthroplasty
patients develop venographically verified DVT.5
A variety of mechanical and pharmacological
approaches have been used to decrease this risk. However,
pharmacological approaches, specifically warfarin sodium
and low molecular weight heparin (LMWH) have received
greatest amount of attention.
Main features of unfractionated heparin include its
sub-optimal efficacy and risk of heparin-induced thrombo-
cytopenia. Warfarin therapy needs regular dose adjustments
and careful laboratory monitoring of PT levels. Advantages
of low molecular weight heparins are enhanced efficacy and
a decreased risk of heparin induced thrombocytopenia. The
optimal duration for therapy is unknown. 
There are two possible explanations for low preva-
lence of DVT in Asian countires.3 Firstly, the number of
joint replacement procedures is much smaller than that in
Western countries.3 Another possible reason is widesoread
use of clinical signs rather than venography as diagnostic
criteria of DVT in Asian countries as clinical signs are
shown to be insensitive and not specific enough in estimat-
ing the true incidence of DVT.1 Accordingly, direct compar-
ison of prevalence of DVT between patients from Asian and
Western countries has been confounded because of the dif-
ferences in diagnostic criteria.2,3 Another factor as a cause
of low incidence of DVT in Asian population is Leiden
mutation that involves point mutation of factor V gene
which prevents the breakdown of factor V resulting in rela-
tive hyper-coaguability. The prevalence of this mutation
was found to be significantly lower in Asian population as
compared to Western population.6-8 This Prothrombin vari-
ant which also predisposes to clotting was found to be
absent in Taiwanese and Japanese population.9
The incidence of asymptomatic DVT after major
orthopaedic surgery in Japanese patients was only 15%.3 In
the Korean population, the incidence of DVT in patients
undergoing total hip replacement surgery was 20% in the
control group not receiving any prophylaxis.10 In the
Singapore population, a very low incidence of DVT was
found in patients not receiving any prophylaxis11. On the
contrary, the incidence of DVT was quite comparable to the
Western figures in Hong Kong12 and Malaysian13 patients.
In a recent venographically confirmed study from Japan3
done on patients undergoing total hip and knee replacement
surgery without any form of prophylaxis, the incidence of
DVT both proximal as well as distal, was found to be high.
Incidence in the Indian patients undergoing various high-
risk surgeries without prophylaxis, was found to be 28%.14
Hence the evidence regarding the prevalence of DVT with-
out using any form of chemoprophylaxis after high-risk
orthopaedic surgeries in Asian population is still equivocal.
Not much has been written about DVT in Pakistan.
In a previous study15, on 750 operated patients in the
orthopaedic service of a private hospital, twenty-five (3.3%)
were identified as clinical DVT. These patients were catego-
rized in two groups, group 1 (n=15) received no prophylax-
is or some prophylaxis other than Warfarin and group 2
(n=10) received Warfarin. There were nine (1.6%) mortali-
ties in this series. Mortality was 0.6% (p<0.06) in group 1
and 1.6% in group 2. It was concluded that incidence of
DVT shown in this study is an understatement; it might
have been much higher if those objective methods were
used. In another study16 on 117 high risk patients undergo-
ing surgery without prophylaxis, Technetium labeled
venography showed 12.82% patients to have DVT. The
study concluded that there is need to give prophylaxis to
high risk patients undergoing surgery especially pelvic sur-
gery.
In a randomized, parallel group, open labeled
study17, the use of LMWH versus unfractioned heparin after
elective TKR surgery in 453 patients showed the incidence
of DVT by venography to be 24.6% in the LMWH group
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and 34.2% in the unfractioned heparin paients.
In another study on 1942 patients subjected to total
joint replacement surgery, DVT was encountered in 9.6%
patients in the LMWH group, 16.1% in the unfractionated
heparin group and 46% in the placebo group.18
In a recent Indian study19 where patients undergoing
total hip replacement surgery were divided in 2 groups and
Doppler scan postoperatively showed no evidence of DVT
in these patients. In another study by same author20 where
DVT was assessed in patients undergoing THR and TKR
surgery, 2 patients developed DVT all of them underwent
THR surgery. The author concluded that the incidence of
DVT in Indian patients is very low and is not comparable
with American and European populations.
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